The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer

The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer

The determination of mutant p53 and the basic parameters studied by DNA-flow cytofluorometry in combination with other clinical and morphological predictors may be used as additional prognostic criteria individually in each patient with breast cancer.

Bibliographic Details
Main Authors: L. K. Tsoi, V. N. Bogatyrev, V. P. Letyagin, Ya. V. Vishnevskaya, A. M. Platova
Format: Article
Language:Russian
Published: ABV-press 2014-08-01
Series:Opuholi Ženskoj Reproduktivnoj Sistemy
Subjects:
breast cancer
dna-flow cytofluorometry
prognostic factors
early forms of breast cancer
mutant p53
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/229
Description
Summary:The determination of mutant p53 and the basic parameters studied by DNA-flow cytofluorometry in combination with other clinical and morphological predictors may be used as additional prognostic criteria individually in each patient with breast cancer.
ISSN:1994-4098
1999-8627

Similar Items